Order Now

Kinch et al suggest that the scaling back of internal R&D by large pharmaceutical companies, the rise of NME acquiring organizations with limited R&D capabilities and the tightening of venture capital funding for early stage biotechnology companies are resulting in a progressive and possibly irreversible shrinking of the R&D infrastructure for drug discovery

1) Explain why you agree or disagree with this statement. 2) Where do you think the next generation of drugs will originate from?

In their concluding remarks, Kinch et al suggest that the scaling back of internal by large pharmaceutical companies, the rise of NME acquiring organizations with limited R&D capabilities and the tightening of venture capital funding for early stage biotechnology companies are resulting in a progressive and possibly irreversible shrinking of the R&D infrastructure for drug discovery. 1) Explain why you agree or disagree with this statement. 2) Where do you think the next generation of drugs will originate from?

 

Order Now

Calculate Your Order Price


Price (USD)
$